Lutz Frolich
Mannheim, BW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 219 publications
Class-level aggregation obscures clinically relevant heterogeneity in anti-amyloid antibody trials: comments on a Cochrane review by individual members of the EADC.
Journal: The journal of prevention of Alzheimer's disease
Published: May 01, 2026
Investigating hepatitis E virus seroprevalence in patients with Alzheimer's disease.
Journal: Frontiers in aging neuroscience
Published: March 16, 2026
Exploring blood-based biomarkers in late-life depression: Correlates of psychotherapeutic treatment outcomes.
Journal: European psychiatry : the journal of the Association of European Psychiatrists
Published: January 23, 2026
Amyloid-related imaging abnormalities (ARIA) in Alzheimer's disease: from pathophysiology to individualized risk assessment.
Journal: Alzheimer's research & therapy
Published: January 06, 2026
Polygenic risk for psychiatric disorders and its association with neuropsychiatric symptoms in dementia.
Journal: International review of psychiatry (Abingdon, England)
Published: December 24, 2025
Cost-effectiveness of the special care unit for persons with dementia.
Journal: The journal of prevention of Alzheimer's disease
Published: December 12, 2025
Assessment of clinical and neuroimaging efficacy of treatment targeting tau pathology in mild cognitive impairment and mild to moderate Alzheimer's disease with hydromethylthionine mesylate using external control data.
Journal: The journal of prevention of Alzheimer's disease
Published: October 07, 2025
Clinical, imaging and blood biomarker outcomes in a Phase 3 clinical trial of tau aggregation inhibitor hydromethylthionine mesylate in mild cognitive impairment and mild to moderate dementia due to Alzheimer's disease.
Journal: The journal of prevention of Alzheimer's disease
Published: October 01, 2025
Cerebrospinal fluid proteome alterations related to depressive symptoms in cognitive decline and Alzheimer's disease.
Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association
Published: September 23, 2025
The German Dementia Registry (DEMREG): study protocol of a biomarker-based national registry for cognitive impairment and dementia.
Journal: Neurological research and practice
Published: September 10, 2025
Donanemab for Alzheimer's disease: from preclinical research to the clinical application.
Journal: Expert review of neurotherapeutics
Published: August 12, 2025
Revising the ABIDE MCI to dementia prediction model for automated cerebrospinal fluid assays.
Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association
Published: July 02, 2025
Last Updated: 09/26/2026